The dollar index (DXY00 ) on Thursday rose by +0.36%. Thursday's decline in equity markets boosted liquidity demand for the dollar. Also, Wednesday night's comments from President Trump that the Iran war could escalate have boosted demand for the dollar as a safe-haven. The dollar added to its gains on...
The dollar index (DXY00 ) on Thursday rose by +0.36%. Thursday's decline in equity markets boosted liquidity demand for the dollar. Also, Wednesday night's comments from President Trump that the Iran war could escalate have boosted demand for the dollar as a safe-haven. The dollar added to its gains on...
JHVEPhoto/iStock Editorial via Getty Images If I had to pick one stock that I have failed to crack, my first pick would be Lumen Technologies, Inc. ( LUMN ). Almost 7 years ago, I made a small profit with LUMN, but since then, the going has been difficult. I was bearish on Lumen when I should have been bullish and vice versa. Last October, after a couple of years sitting on the sidelines, I turned...
JHVEPhoto/iStock Editorial via Getty Images If I had to pick one stock that I have failed to crack, my first pick would be Lumen Technologies, Inc. ( LUMN ). Almost 7 years ago, I made a small profit with LUMN, but since then, the going has been difficult. I was bearish on Lumen when I should have been bullish and vice versa. Last October, after a couple of years sitting on the sidelines, I turned bullish on the prospects for Lumen as I thought the company was on the right track to grow adjusted EBITDA in 2026. Since then, the stock has lost just over 1% of its value. Last January, I made a case for why Lumen deserves to trade at premium valuation multiples compared to legacy telcos. My argument was that Lumen was no longer a legacy telco business but a tech business. LUMN has lost ~15% since then. Now that Lumen has reported Q4 2025 earnings and set a baseline for 2026 expectations, I wanted to revisit my thesis. Rather than looking at all aspects of my thesis, I thought it best to look at the timeline for PCF contract revenue conversion cycles to get a better understanding of when Lumen will finally get a revenue boost from the secured PCF contracts. Understanding When PCF Contracts Hit Revenue Lumen is solving real-world connectivity problems for hyperscalers who are aggressively investing billions of dollars in AI infrastructure. This is where PCF contracts are used. Internet bandwidth through traditional networks has been proven insufficient to handle the data loads required to train LLM models. A PCF contract allows a customer to get access to a private, custom fiber network with a very high capacity and low latency. Some of Lumen's major PCF customers include tech giants such as Microsoft Corporation ( MSFT ), Meta Platforms, Inc. ( META ), Amazon.com, Inc. ( AMZN ), Alphabet Inc. ( GOOG ), and Anthropic (the company behind the widely popular Claude LLM). As highlighted by the management in the Q4 earnings release , Lumen has so far signed PCF contracts worth...
Pete & Gerry's CEO Tom Flocco discusses how overpopulation is reducing the price of eggs for consumers, egg industry challenges, and the rise of protein. He talks with Katie Greifeld on "The Close." (Source: Bloomberg)
Pete & Gerry's CEO Tom Flocco discusses how overpopulation is reducing the price of eggs for consumers, egg industry challenges, and the rise of protein. He talks with Katie Greifeld on "The Close." (Source: Bloomberg)
Energy earnings expectations have risen sharply over recent weeks, with the current +7.6% earnings growth rate expected in 2026 Q1 up from +0.9% a week back and the -1.9% decline expected at the start of January.
Energy earnings expectations have risen sharply over recent weeks, with the current +7.6% earnings growth rate expected in 2026 Q1 up from +0.9% a week back and the -1.9% decline expected at the start of January.
Energy earnings expectations have risen sharply over recent weeks, with the current +7.6% earnings growth rate expected in 2026 Q1 up from +0.9% a week back and the -1.9% decline expected at the start of January.
Energy earnings expectations have risen sharply over recent weeks, with the current +7.6% earnings growth rate expected in 2026 Q1 up from +0.9% a week back and the -1.9% decline expected at the start of January.
Nebius Group recently announced plans to build a new AI “factory” data center campus in Lappeenranta, Finland, with up to 310 MW of capacity, adding to its expanded Mäntsälä site and broader multi‑gigawatt global build‑out. The project, backed by a broader ecosystem that includes large long-term contracts with Microsoft and Meta and a focus on low‑carbon, heat‑recycling infrastructure, underlines ...
Nebius Group recently announced plans to build a new AI “factory” data center campus in Lappeenranta, Finland, with up to 310 MW of capacity, adding to its expanded Mäntsälä site and broader multi‑gigawatt global build‑out. The project, backed by a broader ecosystem that includes large long-term contracts with Microsoft and Meta and a focus on low‑carbon, heat‑recycling infrastructure, underlines how AI compute demand is reshaping regional economies, energy use, and labor markets in Finland...
Never miss an episode. Follow The Big Take daily podcast today. After a month of fighting, President Trump took his case for war with Iran to the American people Wednesday night. In a prime-time address that sent energy markets surging, he promised both an imminent end to the conflict and two to three weeks of further intense military strikes. On today’s Big Take podcast, host Sarah Holder and Blo...
Never miss an episode. Follow The Big Take daily podcast today. After a month of fighting, President Trump took his case for war with Iran to the American people Wednesday night. In a prime-time address that sent energy markets surging, he promised both an imminent end to the conflict and two to three weeks of further intense military strikes. On today’s Big Take podcast, host Sarah Holder and Bloomberg Washington Correspondent Jeff Mason unpack the president’s brief, often contradictory speech. They discuss how it put investors and key allies on the back foot, what it could mean for the president’s agenda heading into the midterms and where the conflict goes from here. We are live blogging our coverage of the war with Iran at Bloomberg.com with the latest from across the globe. Here’s what else we’re watching today: Trump Ousts Bondi After Chaotic Tenure at Justice Department Blue Owl Limits Redemptions on Private Credit Funds After Massive Exit Requests We have a special Bloomberg subscription offer for podcast listeners at Bloomberg.com/podcastoffer. Listen and follow The Big Take on Apple Podcasts , Spotify or wherever you get your podcasts. Terminal clients: click here to subscribe. This episode was produced by: David Fox; Editors: Jeffrey Grocott; Fact-checker: Eleanor Harrison-Dengate and Julia Press; Sound Design/Engineer: Alex Sugiura; Senior Producer: Naomi Shavin; Senior Editor: Elisabeth Ponsot; Deputy Executive Producer: Julia Weaver; Executive Producer: Nicole Beemsterboer.
Victor Golmer/iStock Editorial via Getty Images Investment Thesis Novo Nordisk A/S ( NVO ) competes almost exclusively against Eli Lilly and Company ( LLY ) in a fast growing GLP-1 market. Although the falling stock price may make the company cheap, competition and high reliance on patents raise questions regarding the sustainability of future growth. Eli Lilly seems to currently have a slight adv...
Victor Golmer/iStock Editorial via Getty Images Investment Thesis Novo Nordisk A/S ( NVO ) competes almost exclusively against Eli Lilly and Company ( LLY ) in a fast growing GLP-1 market. Although the falling stock price may make the company cheap, competition and high reliance on patents raise questions regarding the sustainability of future growth. Eli Lilly seems to currently have a slight advantage with tirzepatide, justifying the falling stock price of Novo Nordisk. Nevertheless, Europe and Asia remain attractive markets for Novo Nordisk to capitalize on. Business Overview Novo Nordisk is a Danish pharmaceutical company and with a market cap of ~150 billion USD amongst the biggest companies in all of Europe. Their products c an be divided into four segments . The most important segment, measured by revenue, is diabetes, accounting for 67% of total revenue. Key products are Ozempic and Rybelsus, accounting for 61% and 11% of Diabetes revenue respectively. The second largest segment is obesity at 26.5% of Total revenue, which mainly consists of Wegovy. Ozempic, Rybelsus and Wegovy all consist of semaglutide, a peptide that imitates glucagon. For diabetics, glucagon is the hormone which transfers sugar from the liver into the blood. Obese people make use of semaglutide since glucagon helps lower the appetite and therefore stops cravings. Side effects of this peptide are nausea, vomiting and diarrhea . Ozempic is administered via injection, while Rybelsus has the same function, just as a oral medication. Wegovy can be accessed via injection or orally. Together, these three medications combined account for 73.7% of total revenue and therefore form the core of Novo Nordisk's business. Earlier this year, Wegovy as a 7.2 mg dose was approved, improving weight loss results to 20.7% in 72 weeks, compared to 16.6% achieved by the original 2.4 mg dose. A small friction of revenue (6%) is generated by the rare disease segment, mainly treating blood disorders. Since I do no...
NextPlat ( NXPL ) (NASDAQ: NXPL, NXPLW) on Thursday said that it will implement a 1-for-10 reverse stock split of its common stock, effective before market open on April 13. Following the split, every 10 shares will be consolidated into one share, reducing shares outstanding to about 2.7 million from roughly 26.9 million. The stock will continue trading on Nasdaq under the ticker “NXPL” with a new...
NextPlat ( NXPL ) (NASDAQ: NXPL, NXPLW) on Thursday said that it will implement a 1-for-10 reverse stock split of its common stock, effective before market open on April 13. Following the split, every 10 shares will be consolidated into one share, reducing shares outstanding to about 2.7 million from roughly 26.9 million. The stock will continue trading on Nasdaq under the ticker “NXPL” with a new CUSIP number. No fractional shares will be issued, with shareholders receiving cash in lieu of fractions. NXPL +2.22% after hours to $0.459. Source: Press Release More on NextPlat Most and least shorted communications services stocks with up to $2B market cap as of end-Feb Financial information for NextPlat
JHVEPhoto/iStock Editorial via Getty Images Taiwan Semiconductor Manufacturing Company Limited aka TSMC ( TSM ) is just a few weeks away from reporting Q1 2026 earnings ( expected April 16th ). Giving how important this stock is in the AI trade, I considered writing a pre-earnings note, with an emphasis on the recent developments and the key items I will be monitoring in the release. After the com...
JHVEPhoto/iStock Editorial via Getty Images Taiwan Semiconductor Manufacturing Company Limited aka TSMC ( TSM ) is just a few weeks away from reporting Q1 2026 earnings ( expected April 16th ). Giving how important this stock is in the AI trade, I considered writing a pre-earnings note, with an emphasis on the recent developments and the key items I will be monitoring in the release. After the company delivered what I see as its strongest earnings and guidance since the start of the AI supercycle in Q4 , I downgraded my rating to a Buy. I know, I know. The words "downgrading to a Buy" may seem confusing. To clarify, there is a big difference between fundamentals and price action. Unlike traditional fundamental-driven investors, I believe there are times when these two decouple. Right now is a good example of this (irrational to some) behavior. Back in January, I cited in my note the high risk of a correction in the broader markets. That was the main driver behind my downgrade. I am happy (or sad, actually) that I was right with my prediction, given what has been going on in the markets since the conflict in the Middle East started. I believe this conflict may soon come to an end, and transits through Hormuz will resume again. That's when I believe investors will be back in risk-on mode, and stocks like TSMC may have the highest upside potential. In this article, I discuss why and I provide my view on the upcoming Q1 earnings release. What's New Since Last Earnings Well, as you may know, TSMC releases monthly revenue data, which is one of the key metrics that I monitor between earnings to gauge the health of the AI trade. For January , the company reported revenue of NT$401.26 billion, up 19.8% vs. December 2025 and up 36.8% vs. January 2025. TSMC February was a slower month, as sales declined 20.8% sequentially, but they were still up 22% YOY, so red flags here. TSMC From a guidance perspective, management is looking at US$34.6 billion and US$35.8 billion for Q1 202...